Tag Archive for: American College of Cardiology

cliexa, a Colorado-based digital health company, acquired ProSkedge.com, an automated surgical scheduling platform. cliexa’s end-to-end virtual health platform offers integrated clinical intake, automated documentation and remote patient monitoring solutions tailored to practices in multiple-subspecialty settings. cliexa has partnered with American College of Cardiology co-developing cardiovascular home health monitoring solutions since 2018.

“With the acquisition of ProSkedge, cliexa’s focus on actionable, meaningful and impactful patient reported outcomes now extends to the pre-clinical care portion of healthcare delivery. The integration of scheduling care enhances the patient experience and removes historic hurdles.” – Dr. Gerald Maccioli, Chairman of Advisory Board at cliexa

ProSkedge has been designed and developed by Dr Lukasz Kowalczyk, practicing gastroenterologist with over 10 years of GI and procedure experience. ProSkedge simplifies, automates, and personalizes the scheduling process for clinics and patients. With this acquisition, cliexa-ProSkedge becomes a true end-to-end platform for clinics and health systems, offering solutions from onboarding to post-procedure monitoring to patients.

“Surgical care continues to grow at a high rate and COVID has pushed care out of hospitals and into higher value ASC’s. As cliexa enables the digital delivery of care across ambulatory clinic settings, ProSkedge adds that expertise into the ASC’s and the surgical space. cliexa now offers healthcare organizations a singular, comprehensive system for high value digital transformation across the entire patient journey.” said Dr. Kowalczyk, who is now a board member at cliexa and Chief Medical Officer for GI and Surgical Automation.

Dr. Kowalczyk added, “Colon cancer screening with colonoscopy is a great example of how we can improve the journey for the patient and practice.  New colon cancer screening guidelines drop the initial screening age to 45-49.  This patient demographic, consisting of about 20M people, has shown a higher demand to manage their healthcare through a digital medium like the cliexa-ProSkedge platform.”

Learn more at cliexa.com/ProSkedge

 

The power of remote patient monitoring

There is limited data comparing remote post-discharge patient treatment to that of standard in-person care, but a new clinical trial has done exactly that.

This multicenter randomized control trial measured safety events, medication adjustment and left ventricular reverse remodeling outcomes.  The subjects were low-risk patients with acute myocardial infarction treated for 6 months after discharge by a centralized nurse practitioner–led telehealth program compared with standard in-person care by a cardiologist. There were no differences in achieved medication doses or indices of left ventricular remodeling.

This clinical trial set out to answer an important question for healthcare in a COVID and post-COVID landscape:

“Is remote post-discharge treatment of low-risk patients with acute myocardial infarction by a centralized nurse clinician team under physician supervision feasible and safe?”

The answer is: Absolutely. In fact, it’s both safe and effective.

What’s next?

Researchers now want to conduct a similar clinical trial with higher-risk patients, in an effort to further test the capabilities of remote intensive patient management and care. Read this impactful new study here:

Remote Postdischarge Treatment of Patients With Acute Myocardial Infarction via JAMA Cardiology

The future is here:

cliexa-PULSE Home Health Monitoring Platform co-developed by cliexa and American College of Cardiology

“Imagine the ability to effectively capture RPM in the cardiology’s major disease states – HTN, CHF, CAD, and AFib in an easy-to-use-tool without all the data overload: Enter cliexa!” Dr. Andrew M. Freeman, MD – Director of Clinical Cardiology and Operations Director Cardiovascular Prevention & Wellness at National Jewish Health

Through the ACC Innovation Program with our partners at the American College of Cardiology (ACC), we have developed one of our latest modules, cliexa-PULSE to digitally transform and ultimately optimize cardiovascular care and outcomes. cliexa-PULSE is a mobile application designed for patients to track their symptoms, medications, episodes, complications and daily activity to manage Atrial Fibrillation providing real-time data to their clinicians. The expansion of cliexa-PULSE in 2021 will provide treatment tracking tools for patients with Hypertension, Congestive Heart Failure and Coronary Artery Disease, as well as launching a population health module. cliexa-PULSE is the ideal mobile app for clinicians to fully leverage patient-reported data, improving treatment decision-making and the overall patient experience. Learn more about cliexa-PULSE HERE

 

American College of Cardiology Conference 2020

The American College of Cardiology (ACC) annual conference hosts colleagues from across the industry to collaborate and facilitate discussions around innovation. The ACC.20 conference takes place on March 28-30 in Chicago. cliexa is excited to announce that we will be attending for the second year in a row! Join cliexa at the ACC.20 conference and schedule a demo with our team here!

 

In addition, cliexa’s CEO & Founder, Mehmet Kazgan, will be participating in an open conversation at ACC.20 about mobile healthcare apps. A popular theme in today’s digital healthcare world is to discuss ways to increase patient engagement within a treatment plan. Therefore, the mobile healthcare industry is moving towards increased communication between patients and physicians through smartphone applications. cliexa’s technology allows for an integrated platform with any EMR that seamlessly connects patients and physicians. Equally important, the app improves the accuracy in patient data collection to utilize in reimbursements.

 

On Monday, March 30 from 9:45am – 11:15am, Mehmet will be participating in this open discussion with two other industry leaders on the topic of mobile healthcare applications. This ‘Knowledge and Networking’ session will be an interesting event to sit in on – and you can add it to your conference itinerary beforehand here. Along with Mehmet, the session leaders include Arash Harzand, MD, MBA, and Francoise Marvel, MD. Also, attendees will have the opportunity to ask questions and lead discussions around this engaging topic during the session.

 

UPDATE 3/9/2020: ACC.20 has been cancelled due to growing coronavirus concerns. Please visit the ACC website for updates and more information.